Dr Reinoud Knops (Academic Medical Center, Amsterdam, NL) discusses 4 years results from A Randomized Trial Of Subcutaneous Versus Transvenous Defibrillator Therapy: The PRAETORIAN Trial.
1. Why is PRAETORIAN needed?
2. What was the design, population and endpoints of the study?
3. How long will patients be followed?
4. Were all objectives met?
5. What conclusions should be made from this data?
Interviewer: Victoria Perroud
Recording Specialist: Natascha Wienand